dermatan sulfate has been researched along with sq-23377 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Templeton, DM; Xiao, W | 1 |
| Gross, AR; Theoharides, TC | 1 |
2 other study(ies) available for dermatan sulfate and sq-23377
| Article | Year |
|---|---|
Ca(2+)/calmodulin-dependent protein kinase II inhibition by heparin in mesangial cells.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cell Proliferation; Cells, Cultured; Chondroitin Sulfates; Dermatan Sulfate; Gene Expression Regulation; Glomerular Mesangium; Heparin; Indoles; Ionomycin; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; RNA, Messenger; Signal Transduction; Transfection | 2005 |
Chondroitin sulfate inhibits secretion of TNF and CXCL8 from human mast cells stimulated by IL-33.
Topics: Calcium; Cell Degranulation; Cell Line, Tumor; Chondroitin Sulfates; Dermatan Sulfate; Endocytosis; Fluorescein; Fluorescent Dyes; Gene Expression Regulation; Glycoconjugates; Heparin; Humans; Hyaluronan Receptors; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Interleukin-8; Ion Transport; Ionomycin; Mast Cells; Signal Transduction; Substance P; Tumor Necrosis Factor-alpha | 2019 |